When you are diagnosed with skin cancer, the first question you ask is, “What are my options?”
You are given several options, including Mohs micrographic surgery, excisional surgery, electrosurgery, cryosurgery, and more choices that all have one word in common: surgery. After a while, they all start to run together.
Fortunately, there is another option for removing basal cell and squamous cell carcinoma, and this one does not involve surgery. Superficial Radiotherapy, or SRT, is the non-surgical choice for removing non-melanoma skin cancer, and it can also be used to treat keloid scarring. Superficial Radiotherapy is safe and effective at treating skin cancer, and it does not come along with the cutting, scarring, healing and recovery time that surgery requires.
Sensus Healthcare offers a non-surgical route of skin cancer treatment options using the SRT-100™, an alternative to invasive incisions that damage your skin’s healthy tissue and cause more unsightly scarring. The SRT-100™ is the revolutionary of skin cancer treatment options, delivering a precise, calibrated dose of Superficial Radiotherapy just skin deep. This way, the radiation safely eliminates your non-melanoma skin cancer cells.
If surgical skin cancer treatment options are a health risk for you, the SRT-100™ is a great choice for you, with cure rates that compete with those of surgical treatments. You can destroy your skin cancer without any collateral damage to your healthy skin cells using the SRT-100™. You are also at less risk for infection and scarring by choosing the SRT-100™.
Now that you know your skin cancer treatment options, what choice will you make? Will you choose to undergo a surgery that involves incisions, pain, scarring, and a great deal of time? Or will you choose the non-surgical, painless, and efficient option–Superficial Radiotherapy by the SRT-100™?
To learn more about the SRT-100™ or to find an SRT-100™ physician near you, contact Sensus Healthcare today, and we will be glad to answer any questions you have about the non-surgical treatment of non-melanoma skin cancer and keloid scarring.
